#allergy diagnostics market share

[mordorintelligencemarketresearch]

The Allergy Diagnostics Market: A Deep Dive into the Surge in Demand and Innovation

The Allergy Diagnostics Market is valued at USD 6.31 billion in 2024 and is projected to grow to USD 10.76 billion by 2029, registering a compound annual growth rate (CAGR) of 11.25% during the forecast period (2024-2029).

Market Overview:

The allergy diagnostics market is witnessing significant growth due to increasing allergic conditions globally, advancements in diagnostic technologies, and growing awareness about the importance of early detection and personalized treatment. As environmental factors and lifestyle changes contribute to a higher incidence of allergies, the demand for effective and accurate allergy tests is rising. The market is expected to expand rapidly over the coming years, driven by both innovative developments in diagnostic equipment and a growing market for immunotherapy solutions.

Key Trends:

Technological Advancements in Diagnostic Methods: The rise of molecular diagnostics, including the use of biomarkers and next-gen sequencing (NGS) technologies, has significantly improved the accuracy and speed of allergy testing.

Growing Demand for Point-of-Care Testing: Increasing consumer preference for at-home testing and immediate results is driving the demand for point-of-care allergy diagnostic solutions.

Expansion of Allergy Panels and Personalized Testing: The use of comprehensive allergy panels that cover a broad spectrum of allergens is on the rise, allowing for more personalized and effective treatments for patients.

Increased Investment in Research and Development: Companies are focusing on developing innovative, user-friendly, and affordable diagnostic tools, with increased funding for allergy research leading to novel test solutions.

Rising Awareness and Education: Public awareness campaigns and educational programs about the impact of allergies are contributing to a more proactive approach to allergy diagnosis and treatment.

Challenges:

High Costs of Advanced Diagnostic Technologies: The adoption of sophisticated allergy testing solutions is often hindered by high costs, making them less accessible for a large portion of the population.

Lack of Standardization in Diagnostic Procedures: Despite advancements, the inconsistency in testing methods and lack of standardized procedures in allergy diagnostics can lead to inaccurate or variable results.

Regulatory Challenges: Navigating the regulatory environment for allergy diagnostic devices, particularly in regions with stringent approval processes, can slow down product development and market entry.

Limited Access in Developing Markets: Limited healthcare infrastructure and awareness in emerging markets can create barriers for the widespread adoption of allergy diagnostic tools, especially in rural or underserved areas.

Conclusion:

The allergy diagnostics market is on a growth trajectory, fueled by technological innovations, an increasing prevalence of allergic conditions, and expanding consumer demand for accessible testing solutions. However, challenges such as high costs, regulatory hurdles, and limited access in developing regions may affect overall market penetration. With continuous advancements in diagnostic techniques and greater awareness, the market is well-positioned for significant expansion in the coming years, offering new opportunities for both established players and new entrants in the industry.

[healthcaremarketanalysis]

Allergy Diagnostics Industry worth $9.8 billion by 2029, with a CAGR of 11.0%

Allergy Diagnostics Market in terms of revenue was estimated to be worth $5.3 billion in 2024 and is poised to reach $9.8 billion by 2029, growing at a CAGR of 11.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.

Download PDF Brochure

Browse in-depth TOC on “Allergy Diagnostics Market”

248 — Tables

57 — Figures

307 — Pages

The consumables segment is expected to account for the largest share in 2023.

The Allergy Diagnostics market, by product & service, has been segmented into consumables, instruments, and services. The consumables segment accounted for the largest share of the Allergy Diagnostics market in 2023. This segment is also anticipated to experience significant growth over the projected period. The increasing demand for rapid diagnosis of allergic patients which is driven by increasing number of allergic cases can be attributed for the larger share of this segment during the forecast period.

In Vivo test segment held the largest market share in the Allergy Diagnostics market.

Based on the test type, the Allergy Diagnostics market is segmented into in vivo tests and in vitro tests. In 2023, the in vivo tests segment accounted for the largest share of the Allergy Diagnostics market. The growth of this segment is mainly driven by the growing adoption of various in vivo tests, such as skin prick tests which is considered as the first line of diagnosis for allergy and favorable government support and guidelines.

Inhaled allergy segment held the largest market share in the Allergy Diagnostics market.

Based on the allergen, the Allergy Diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2023, the inhaled allergens segment accounted for the largest share of the Allergy Diagnostics market due to the rising environmental pollution, rising home dust & mites coupled with other factors such as pollen, fungus, mold, and dust, and switching lifestyles, including rise in indoor activities and exposure to indoor allergen.

North America dominates the global Allergy Diagnostics market

Based on the region, the Allergy Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America market is driven by availability of technologically advanced products and growing research on allergy by companies and government. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. Developing healthcare infrastructure, lifestyle changes and climatic conditions, increased ozone and industrial pollution levels, and the rising demand for quality medical care are some of the major factors driving the growth of this regional market.

Request Sample Pages

Allergy Diagnostics Market Dynamics:

Drivers:

1. High incidence and heavy economic burden of allergic diseases

Restraints:

1. High pricing of allergy diagnostic instruments

Opportunities:

1. Integration of AI in allergy diagnosis

Challenge:

1. Shortage of allergists

Key Market Players of Allergy Diagnostics Industry:

Major players in Allergy Diagnostics market include Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan), Minaris Medical America, Inc. (US).

Breakdown of supply-side primary interviews by company type, designation, and region:

· By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)

· By Designation: C-level (30%), Director-level (20%), and Others (50%)

· By Region: North America (36%), Asia- Pacific (27%), Europe (25%), and Latin America- (7%) and MEA-(5%)

Get 10% Free Customization on this Report:

Recent Developments of Allergy Diagnostics Industry:

· In 2023, Canon has completed share transfer procedures with Resonac Corporation. This share transfer is intended to be used to purchase the Resonac subsidiaries Minaris Medical Co., Ltd. and Minaris Medical America, Inc. (collectively, “Minaris Medical”). After this share acquisition is finished, Minaris Medical — which runs companies that deal with automated analytical tools and in vitro diagnostic reagents — will be consolidated under Canon Medical.

· In 2023, Romer Labs Division Holding GmbH (Austria) acquired CPAK INTER Co., Ltd. (Thailand), a long-time distributor of Romer Labs solutions based in Bangkok. With the acquisition, Romer Labs has achieved yet another significant milestone in the quickly expanding Asian food safety industry.

· In 2022, The US Food & Drug Administration (FDA) has cleared ImmunoCAP Specific IgE (sIgE) Allergen Components for use in in vitro diagnostic testing for wheat and sesame allergies, according to a statement from Thermo Fisher Scientific, Inc. (US).

Allergy Diagnostics Market — Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Allergy Diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

· Analysis of key drivers (global rise in prevalence and heavy economic burden of allergic illnesses, growing environmental pollution, and insurance coverage), restraints (high costs of analyzers and access is limited to healthcare services), opportunities (use of mHealth and integration of AI in allergy diagnosis), and challenges (a few number of allergists and challenges during diagnosis of allergy) influencing the growth of the Allergy Diagnostics market

· Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Allergy Diagnostics market.

· Market Development: Comprehensive information about lucrative markets — the report analyses the Allergy Diagnostics market across varied regions.

· Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Allergy Diagnostics market

· Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan) [Minaris Medical America, Inc. (US)], among others in the Allergy Diagnostics market strategies.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies — helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1–888–600–6441

UK +44–800–368–9399

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/

Content Source:

[researchlog123]

Global Allergy Diagnostics Market

Global Allergy Diagnostics Market Size, Share And Trend By 2031

[lovelypol]

Self-Testing Market to Soar: $8.2B in 2023 to $18.5B by 2033 with 8.4% CAGR

Self-Testing Market is revolutionizing the way individuals manage their health, offering convenient, private, and accessible diagnostic solutions without requiring professional medical assistance. From home testing kits for diabetes and pregnancy to advanced genetic and infectious disease tests, this market reflects the growing demand for personalized healthcare.

To Request Sample Report: https://www.globalinsightservices.com/request-sample/?id=GIS26806 &utm_source=SnehaPatil&utm_medium=Article

Key Market Drivers ��

Technological Advancements: Innovations in molecular diagnostics, biosensors, and smartphone-connected devices enhance accuracy and ease of use.

Increased Health Awareness: Rising focus on preventive care and early diagnosis drives adoption.

Demand for Privacy: Home-based testing provides a discreet and comfortable alternative for individuals.

Market Highlights

Leading Segments:

Glucose Monitoring Kits: Capture 45% market share, driven by the growing prevalence of diabetes and the need for continuous health monitoring.

Pregnancy & Fertility Test Kits: Account for 30% market share, reflecting the rising importance of reproductive health management.

Infectious Disease Test Kits: Hold 25% market share, propelled by post-pandemic health consciousness and demand for rapid diagnostics.

Regional Insights:

North America: Leads the market with a proactive approach to personal health management and advanced healthcare infrastructure.

Europe: Benefits from strong government support and widespread adoption of self-testing kits.

Asia-Pacific: Exhibits rapid growth due to increased healthcare spending, a growing middle class, and rising awareness of self-diagnosis.

Market Segmentation

By Type: Rapid Tests, Laboratory Tests, Point-of-Care Tests, Home Tests, Self-Collection Kits, Digital Tests.

By Product: Blood Glucose Monitors, Pregnancy Tests, COVID-19 Tests, STD Tests, Allergy Tests, Genetic Tests, Cholesterol Tests.

By Services: Consultation, Diagnostic, Monitoring, Data Analysis Services.

By Technology: Lateral Flow Assays, Immunoassays, Molecular Diagnostics, Biosensors, Microfluidics.

By Application: Diabetes Management, Infectious Disease Detection, Cardiovascular Health, Fertility & Pregnancy, Genetic Screening, Cancer Screening.

By Device: Handheld Devices, Wearable Devices, Smartphone-Connected Devices.

By End User: Individuals, Healthcare Providers, Diagnostic Laboratories, Research Institutes.

By Functionality: Single-use, Reusable, Connected, Standalone.

By Mode: Online Platforms, Retail Stores, Pharmacies.

Market Outlook 🚀

2023 Volume: Approximately 300 million units, projected to grow as innovations in self-testing continue to improve accessibility and affordability.

Key Players: Roche Diagnostics, Abbott Laboratories, Everlywell, and LetsGetChecked are leading the market by expanding their product portfolios and integrating AI-driven analysis for accurate diagnostics.

#SelfTesting #HealthTech #GlucoseMonitoring #PregnancyTests #InfectiousDiseaseTests #PersonalizedHealthcare #RapidDiagnostics #MolecularDiagnostics #HealthInnovation #PreventiveCare #ConnectedHealth #HomeDiagnostics #WearableTech #DigitalHealth #FutureOfHealthcare

[neha24blog]

Pediatric Allergy Diagnostics Market Outlook On The Basis Of Product, Allergen, Test, Region And Forecast To 2030: Grand View Research Inc.

San Francisco, 29 Nov 2024: The Report Pediatric Allergy Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Allergen (Food, Inhaled, Drug), Test (In Vivo Test, In Vitro Test), By Region, And Segment Forecasts, 2024 – 2030 The global pediatric allergy diagnostics market is anticipated to reach USD 4.68 billion by 2030 and is projected to grow at a…

[industrynewsupdates]

Future of Enteric Disease Testing Market: Trends and Predictions

The global enteric disease testing market was valued at USD 3.81 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2030. The key drivers for this growth include technological advancements, increased government funding, and growing global demand for early diagnostic solutions. These factors are enhancing the applicability of enteric disease testing, contributing to the expansion of the market.

Technological advancements play a crucial role in accelerating the market's growth. One notable example is the development of gastrointestinal panel tests. These tests enable the rapid and simultaneous identification of multiple parasitic, bacterial, and viral nucleic acids in individuals who exhibit signs of gastroenteritis or infectious colitis. The tests, which are typically performed on stool or saliva samples, can identify up to 15 pathogens within just 6 hours, making them highly efficient. Additionally, these tests can be used to detect inherited food sensitivities or allergies caused by organisms such as Toxoplasma gondii and Entamoeba histolytica, which are known to affect the gastrointestinal system.

These advanced diagnostic tools have already been approved by regulatory bodies like the U.S. FDA, further boosting their credibility and adoption. For instance, the XTAG Gastrointestinal (GPP) test, approved in November 2019, is a multiplexed nucleic acid test designed to detect a range of viral, parasitic, and bacterial pathogens in stool samples. As clinical studies continue to advance and more diagnostic tests with higher accuracy and performance are developed, the market is expected to experience significant growth.

Gather more insights about the market drivers, restrains and growth of the Enteric Disease Testing market

Regional Insights

Europe

Europe held the dominant share of the global enteric disease testing market, accounting for 39.0% of the total revenue in 2022. The region's leadership can largely be attributed to Germany, which holds a significant portion of the market. Germany's large geriatric population plays a pivotal role in driving the demand for enteric disease testing. According to the United Nations population data, one in every 20 individuals in Germany is over the age of 80, and this proportion is expected to increase to one in every 6 people by 2050. Additionally, individuals over the age of 65 made up 22.4% of the total population in 2019, amounting to 90.4 million elderly people in Europe.

The aging population presents unique challenges, including an increased susceptibility to enteric diseases, due to the aging process and declining immunity in older adults. As these individuals face a higher risk of infection, the need for rapid diagnostic solutions like point-of-care diagnostic devices becomes crucial. These diagnostic devices allow for quicker detection and treatment, reducing the risks associated with delayed diagnosis. To meet this demand, major market players, such as Roche and Bio-Rad, are strengthening their presence in Germany, which is expected to further boost the market for enteric disease testing in Europe.

Asia Pacific

The Asia Pacific region is anticipated to grow at the fastest compound annual growth rate (CAGR) of 4.0% from 2023 to 2030. This growth is primarily fueled by increasing awareness about the importance of early testing and the rising incidence of enteric infections. Developing nations like China and India are expected to be key drivers of this growth due to their large populations, rapidly expanding healthcare sectors, and government efforts to increase access to diagnostic services.

In particular, Bangladesh reports the highest number of typhoid cases globally, with 252 cases per 100,000 people, highlighting the growing need for efficient enteric disease testing in the region. As the prevalence of these diseases rises, there is a significant demand for improved diagnostic tools and testing capabilities. The increasing awareness among the population about the benefits of early detection will likely contribute to the rapid growth of the market in Asia Pacific.

Brazil

Brazil presents significant opportunities for growth in the enteric disease testing market, supported by economic growth and political stability. Recent improvements in the Brazilian economy have led to better healthcare access, creating a favorable environment for the expansion of diagnostic services.

One key development in Brazil is the Unified Health System (SUS), which provides free healthcare services to all individuals, regardless of their financial status. The SUS system integrates public, private, and supplemental healthcare services, making healthcare more accessible to a larger portion of the population.

Additionally, government initiatives such as collaborations between the U.S. and Brazil in biomedical research are accelerating the research and development of diagnostic technologies for infectious diseases. These efforts are expected to further boost the demand for enteric disease testing in the country. However, challenges remain, as advanced diagnostics are currently more accessible in urban areas due to limited healthcare infrastructure in rural regions, which could potentially slow down overall market growth.

Browse through Grand View Research's  Medical Devices Industry Research Reports.

• The global medical simulation market size was estimated at USD 1.65 billion in 2024 and is expected to grow at a CAGR of 16.80% from 2025 to 2030. 

• The global intraoperative neuromonitoring market size was estimated at USD 3.49 billion in 2024 and is anticipated to grow at a CAGR of 5.97% over the forecast period.

Key Companies & Market Share Insights

The enteric disease testing market is highly competitive, with key players focusing on technological advancements and new product development to enhance their market position and offer cost-effective solutions. Several major players have made strategic moves to strengthen their presence in this market.• BD (Becton, Dickinson and Company) launched an ultra-high-throughput molecular diagnostic platform in May 2022 for infectious diseases, specifically in the U.S. This fully automated system is designed to improve diagnostic accuracy and speed, catering to the growing demand for point-of-care testing.

• Thermo Fisher Scientific, Inc. made a significant move in February 2021 by acquiring Mesa Biotech, aiming to expand the reach of molecular diagnostics at the point of care. This acquisition aligns with the company's strategy to strengthen its position in the infectious disease diagnostic space.

Key Enteric Disease Testing Companies

Some of the major players contributing to the global enteric disease testing market include:

• Abbott

• BD (Becton, Dickinson and Company)

• Biomerica

• BIOMÉRIEUX

• Bio-Rad Laboratories, Inc.

• Cepheid

• Coris BioConcept

• DiaSorin S.p.A.

• Meridian Bioscience

• Quest Diagnostics Incorporated

Order a free sample PDF of the Enteric Disease Testing Market Intelligence Study, published by Grand View Research.

[harshnews]

Peanut Allergy Treatment Market Size, Share, Key Drivers, Trends, Challenges and Competitive Analysis

"Peanut Allergy Treatment Market – Industry Trends and Forecast to 2028

Global Peanut Allergy Treatment Market, By Drug Type (Injectable Epinephrine, Antihistamines), Route of Administration (Oral, Injectable), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Access Full 350 Pages PDF Report @

**Segments**

- Allergen-Specific Immunotherapy - Epinephrine Auto-Injector - Anti-Inflammatory Drugs - Others

The peanut allergy treatment market can be segmented into different categories based on the type of treatment options available. Allergen-specific immunotherapy is a promising treatment approach that aims to desensitize the immune system to peanuts gradually. This method involves exposing individuals to small amounts of peanut allergen under controlled circumstances to build tolerance. Epinephrine auto-injectors are crucial for emergency situations where individuals experience severe allergic reactions known as anaphylaxis. Anti-inflammatory drugs such as corticosteroids may be prescribed to reduce inflammation and manage symptoms. Other treatments may include dietary management and alternative therapies.

**Market Players**

- Aimmune Therapeutics - DBV Technologies - DB Allergy - Allergy Therapeutics - Monsanto - Sanofi - Aravax

Several key players contribute significantly to the peanut allergy treatment market. Aimmune Therapeutics is known for its innovative product Palforzia, the first FDA-approved oral immunotherapy for peanut allergy. DBV Technologies focuses on developing Viaskin, an epicutaneous patch for immunotherapy delivery. DB Allergy offers diagnostic tools and therapeutic solutions for allergies, including peanut allergies. Allergy Therapeutics specializes in allergy vaccines and immunotherapy products. Sanofi, a multinational pharmaceutical company, has a presence in the peanut allergy treatment market through its research and development initiatives. Monsanto, a prominent player in agriculture, invests in biotechnology for developing allergy-resistant crops. Aravax is a biopharmaceutical company dedicated to creating novel treatments for food allergies, including peanuts.

https://www.databridgemarketresearch.com/reports/global-peanut-allergy-treatment-marketThe peanut allergy treatment market is witnessing significant growth and innovation driven by the increasing prevalence of peanut allergies worldwide. The focus on developing effective and safe treatment options has led to a surge in research and development activities by key players in the market. Allergen-specific immunotherapy, particularly oral immunotherapy, has emerged as a promising approach to desensitize individuals to peanuts gradually. This method holds the potential to transform the management of peanut allergies by reducing the risk of severe allergic reactions and improving quality of life for patients. The introduction of products like Palforzia by Aimmune Therapeutics and Viaskin by DBV Technologies has showcased the potential of immunotherapy in addressing peanut allergies.

In addition to immunotherapy, the market for epinephrine auto-injectors remains crucial for managing severe allergic reactions, such as anaphylaxis, in individuals with peanut allergies. The availability of user-friendly and portable auto-injectors has enhanced the emergency preparedness of patients and caregivers, emphasizing the importance of timely intervention during allergic episodes. Anti-inflammatory drugs, including corticosteroids, play a role in managing inflammation and symptoms associated with peanut allergies, providing supplementary support alongside allergen-specific immunotherapy and emergency treatments.

Moreover, dietary management and alternative therapies are gaining traction as complementary approaches to peanut allergy treatment. Dietary adjustments, such as strict avoidance of peanuts and label reading, are essential for preventing allergic reactions and ensuring the safety of individuals with peanut allergies. Alternative therapies, including herbal remedies and probiotics, are being explored for their potential immunomodulatory effects on allergic responses. The integration of these holistic approaches into patient care plans underscores the multidimensional nature of managing peanut allergies and the need for personalized treatment strategies.

Furthermore, the market landscape is characterized by the presence of leading pharmaceutical companies, biotechnology firms, and research organizations dedicated to advancing peanut allergy treatment options. Collaborative efforts among industry players, academic institutions, and regulatory bodies are driving innovation and fostering a conducive environment for bringing novel therapies to market. The continuous**Global Peanut Allergy Treatment Market**

- **Injectable Epinephrine** - **Antihistamines**

The global peanut allergy treatment market is experiencing significant growth and innovation, driven by the rising prevalence of peanut allergies worldwide. Allergen-specific immunotherapy, notably oral immunotherapy, has emerged as a promising approach to gradually desensitize individuals to peanuts, potentially transforming the management of peanut allergies by reducing severe allergic reactions and improving patients' quality of life. Key market players such as Aimmune Therapeutics, DBV Technologies, and Allergy Therapeutics are at the forefront of developing innovative treatment options in this segment.

Epinephrine auto-injectors play a critical role in managing severe allergic reactions, such as anaphylaxis, in individuals with peanut allergies. The availability of user-friendly and portable auto-injectors has improved emergency preparedness among patients and caregivers, emphasizing the importance of timely intervention during allergic episodes. Additionally, anti-inflammatory drugs, including corticosteroids, supplement allergen-specific immunotherapy and emergency treatments by managing inflammation and associated symptoms in peanut allergy patients.

Dietary management and alternative therapies are emerging as complementary approaches to peanut allergy treatment. Strict avoidance of peanuts, label reading, and dietary adjustments are essential in preventing allergic reactions and ensuring patient safety. Research into alternative therapies such as herbal remedies and probiotics for their potential immunomodulatory effects on allergic responses is ongoing, highlighting the holistic nature of peanut allergy management and the importance of personalized treatment strategies.

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Peanut Allergy Treatment Market Landscape

Part 04: Global Peanut Allergy Treatment Market Sizing

Part 05: Global Peanut Allergy Treatment Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Peanut Allergy Treatment Key Benefits over Global Competitors:

The report provides a qualitative and quantitative analysis of the Peanut Allergy Treatment Market trends, forecasts, and market size to determine new opportunities.

Porter’s Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.

Top impacting factors & major investment pockets are highlighted in the research.

The major countries in each region are analyzed and their revenue contribution is mentioned.

The market player positioning segment provides an understanding of the current position of the market players active in the Personal Care Ingredients

Browse Trending Reports:

Threat Detection Systems Market Pipe Coating Market Fragrance Fixatives Market Mobile Campaign Management Platform Market Menstrual Cramps Treatment Market Roof Insulation Market Mobile Robotics Market Varnish Makers Market Urinary Incontinence Market Treatment Resistant Depression Market Robotic Prosthetics Market Neutropenia Market Polycystic Kidney Disease Adpkd Market Grain Analysis Market Solid State Solar Cell Market Panel Mount Industrial Display Market Automotive Mini Led Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[market-insider]

Food Allergy Diagnostics And Therapeutics Market Insights: Detailed Overview of Market Size, Share, Projected Growth

The global food allergy diagnostics and therapeutics market size is expected to reach USD 13.28 billion by 2030, registering a CAGR of 8.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow in the coming years owing to increasing incidence of food allergies coupled with rising demand for products for management of these conditions.

Food Allergy Diagnostics And Therapeutics Market Report Highlights

Therapeutics segment dominated the market in 2023 due to growing demand for antihistamines and epinephrine auto-injector

Diagnostic segment includes instruments, consumables, and services, wherein consumables expected to grow at the fastest CAGR during the forecast period

The most common tests used to diagnose food allergies are skin prick tests and blood tests

Peanut allergen source segment is anticipated to register lucrative growth over the forecast period, owing to novel product launches coupled with rising incidence of peanut allergies worldwide.

Hospitals & clinics dominated the food allergy diagnostics & therapeutics market in 2023 owing to increase in number of hospitalizations due to severe allergic conditions

For More Details or Sample Copy please visit link @: Food Allergy Diagnostics And Therapeutics Market Report

Medical was the largest application for PEG, accounting for more than 40% of market share in 2022. Superior blending, hygroscopicity, and non-toxic properties of PEG have resulted in high demand for the chemical in numerous pharmaceutical products such as tablets and ointments. Increasing pharmaceutical expenditure, particularly in emerging economies of India, China, and Brazil, is expected to boost PEG market over the forecast period. Growing demand for paints & coatings coupled with the increasing use of PEG as a solvent due to its low VOC emissions is anticipated to fuel market growth over the next six years.

However, administering epinephrine using an auto-injector during the early stage of anaphylaxis might help avoid any serious complications. Treatment for food allergy costs around USD 25 billion annually in the U.S. Development of cost-effective in vitro diagnostic tests for detection of allergy is expected to fuel the demand for diagnostic products.

List of major companies in the Food Allergy Diagnostics And Therapeutics Market

Astellas Pharma, Inc.

Aimmune Therapeutics

Meridian Medical Technologies

ALK-Abelló Ltd

Medeca Pharma AB

bioMeriux SA

Omega Diagnostics Group PLC

HYCOR Biomedical

HOB Biotech Group Corp Ltd.

Cambridge Allergy Ltd

Medeca Pharma AB

For Customized reports or Special Pricing please visit @: Food Allergy Diagnostics And Therapeutics Market Analysis Report

We have segmented the global artificial food allergy diagnostics and therapeutics market based on product, allergen source, end-use, and region.

[heathcareforallworld]

Exploring the IgE Test Market: Size, Share, and Growth Opportunities Through 2032

Introduction

The global immunoglobulin E (IgE) test market has experienced steady growth in recent years, driven by increasing awareness of allergic diseases, rising prevalence of asthma and food allergies, and advances in diagnostic technologies. IgE tests are a critical diagnostic tool used to detect allergic responses to specific substances, making them essential in allergy management and treatment.

Market Size and Forecast

Ige Test Market Size was estimated at 1.84 (USD Billion) in 2023. The Ige Test Market Industry is expected to grow from 1.9 (USD Billion) in 2024 to 2.5 (USD Billion) by 2032. The Ige Test Market CAGR (growth rate) is expected to be around 3.49% during the forecast period (2024 - 2032).Factors contributing to this growth include increasing healthcare expenditure, rising incidences of allergic conditions, and the demand for early diagnosis and treatment of allergies.

The adoption of IgE tests has been expanding globally, especially in regions where allergic conditions such as rhinitis, asthma, and food allergies are becoming more prevalent. With the continuous rise in these allergic conditions, coupled with advancements in diagnostic technologies, the IgE test market is poised for substantial growth through 2032.

Market Share Analysis

The IgE test market is highly competitive, with several key players dominating the landscape. Some of the leading companies in this sector include Thermo Fisher Scientific, Sysmex Corporation, EKF Diagnostics, Siemens Healthineers, Roche Diagnostics. These companies hold a significant share of the market due to their strong product portfolios, advanced diagnostic technologies, and extensive distribution networks.

Hospitals, diagnostic laboratories, and specialty clinics are the primary end-users of IgE tests, as they rely on these diagnostic tools to identify and manage allergic diseases. Diagnostic laboratories, in particular, hold a substantial share of the market due to the growing trend of outsourcing laboratory services to specialized facilities that can offer efficient, high-volume testing.

Geographically, North America is the largest market for IgE tests, primarily due to the region’s well-established healthcare infrastructure, high prevalence of allergies, and growing demand for allergy diagnostics. Europe follows closely, driven by increasing allergy cases and advancements in medical technology. However, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period, as healthcare awareness and expenditure continue to rise in countries like China and India.

Key Market Drivers

Rising Prevalence of Allergic Diseases: The increasing incidence of allergic diseases such as asthma, food allergies, and allergic rhinitis is one of the primary drivers of the IgE test market. The World Allergy Organization (WAO) reports that over 20% of the global population suffers from allergic conditions, and this number is expected to rise. As a result, the demand for IgE tests is growing, as these tests are essential in diagnosing allergies and determining specific allergen sensitivities.

Advancements in Diagnostic Technologies: Technological advancements in allergy diagnostics have made IgE tests more accurate, faster, and easier to use. The development of automated diagnostic platforms has revolutionized allergy testing, enabling faster and more efficient processing of large volumes of samples. Moreover, innovations such as point-of-care testing (POCT) are expanding the accessibility of IgE tests, allowing for more rapid diagnosis and treatment.

Increasing Awareness and Early Diagnosis: Growing awareness of the impact of allergic diseases on health is driving the demand for early diagnosis. Healthcare providers and patients alike are recognizing the importance of timely and accurate allergy testing in managing conditions such as asthma and food allergies. Early diagnosis allows for better disease management, reducing the burden on healthcare systems and improving patient outcomes.

Rising Healthcare Expenditure: The global increase in healthcare spending, especially in emerging economies, is expected to drive the growth of the IgE test market. As governments and private organizations invest in healthcare infrastructure, the demand for diagnostic services, including IgE testing, is likely to rise.

Market Trends

Shift Toward Personalized Medicine: There is a growing trend toward personalized medicine in allergy treatment, with a focus on identifying specific allergens that trigger symptoms in individual patients. IgE tests play a key role in this approach, providing clinicians with the information needed to tailor treatment plans to the unique needs of each patient.

Increasing Use of Point-of-Care Testing (POCT): The adoption of point-of-care IgE testing is on the rise, particularly in outpatient and home healthcare settings. POCT offers several advantages, including faster results, convenience, and ease of use, making it an attractive option for healthcare providers and patients. As the technology continues to improve, it is expected to play a significant role in the future of IgE testing.

Rising Demand for At-Home Allergy Testing Kits: The growing demand for at-home testing solutions is another trend shaping the IgE test market. At-home allergy testing kits allow individuals to test for specific allergens from the comfort of their homes, providing a convenient alternative to traditional laboratory-based tests. This trend is expected to gain momentum as consumers increasingly seek accessible healthcare solutions.

Focus on Emerging Markets: The IgE test market is expanding rapidly in emerging markets such as Asia-Pacific and Latin America. These regions are experiencing a rise in allergic conditions due to changing environmental factors, urbanization, and increasing awareness of healthcare. Governments and private healthcare providers in these regions are investing in allergy diagnostics, providing significant growth opportunities for market players.

Conclusion

The IgE test market is poised for significant growth through 2032, driven by rising awareness of allergic diseases, technological advancements in diagnostics, and increasing healthcare expenditure. As personalized medicine and point-of-care testing become more prevalent, the demand for IgE tests will continue to rise. Emerging markets present new opportunities for growth, as healthcare infrastructure and awareness expand in regions such as Asia-Pacific and Latin America. With its crucial role in allergy diagnostics and disease management, the IgE test market is set to play an increasingly important role in global healthcare.

[credenceresearchdotblog]

The Cord Blood Product Market is projected to grow from USD 834.19 million in 2024 to USD 1,198.15 million by 2032, reflecting a compound annual growth rate (CAGR) of 4.63%.The global pharmaceutical landscape is vast and dynamic, with various segments witnessing growth driven by innovation, demand, and changing consumer health needs. One such segment is the Hydroxyzine market. Hydroxyzine, an antihistamine with anticholinergic and sedative properties, is primarily used to treat allergy symptoms, anxiety, and nausea, and as a preoperative sedative. This article explores the current state of the Hydroxyzine market, its growth drivers, challenges, and future outlook.

Browse the full report at https://www.credenceresearch.com/report/cord-blood-product-market

Market Overview

The Hydroxyzine market is an essential part of the global pharmaceutical sector, driven by its widespread use in treating a variety of conditions. Hydroxyzine is available in several forms, including tablets, capsules, syrups, and injections, making it a versatile drug for different age groups and medical needs. The market encompasses both generic and brand-name versions, with generic drugs being more prevalent due to cost-effectiveness.

In recent years, the demand for Hydroxyzine has been steadily increasing, owing to its broad therapeutic applications. The drug is commonly prescribed for managing anxiety, a condition that has seen a significant rise globally due to increasing stress levels in modern life. Additionally, its use in allergy treatment contributes to its market demand, particularly during allergy seasons.

Market Drivers

Several factors contribute to the growth of the Hydroxyzine market:

1. Rising Prevalence of Anxiety and Allergic Conditions: The global increase in anxiety disorders and allergic reactions has fueled the demand for Hydroxyzine. With mental health gaining more attention, Hydroxyzine's role as an anxiolytic is particularly significant. The World Health Organization (WHO) estimates that nearly 264 million people worldwide suffer from anxiety disorders, many of whom benefit from medications like Hydroxyzine.

2. Expansion of Healthcare Infrastructure: The ongoing expansion and improvement of healthcare infrastructure in emerging economies have made medications like Hydroxyzine more accessible. Governments and private sectors in countries like India, China, and Brazil are investing heavily in healthcare, which is expected to boost the availability and sales of Hydroxyzine.

3. Generic Drug Market Growth: The patent expiration of many brand-name drugs has led to the proliferation of generic versions. Generic Hydroxyzine is widely available and affordable, driving its adoption across various regions. The cost-effectiveness of generics makes them a preferred choice for both patients and healthcare providers, further propelling market growth.

4. Increased Awareness and Diagnosis: Growing awareness about mental health and allergic conditions, along with improved diagnostic techniques, has led to more prescriptions of Hydroxyzine. Early diagnosis and treatment are crucial, and Hydroxyzine's effectiveness in managing symptoms makes it a popular choice among healthcare professionals.

Challenges Facing the Market

Despite its growth prospects, the Hydroxyzine market faces several challenges:

1. Side Effects and Alternatives: Like many medications, Hydroxyzine is associated with side effects such as drowsiness, dry mouth, and blurred vision. These side effects can limit its use, particularly in patients who need to remain alert. Additionally, the availability of alternative medications with fewer side effects poses a challenge to Hydroxyzine's market share.

2. Regulatory Hurdles: The pharmaceutical industry is heavily regulated, and Hydroxyzine is no exception. Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have stringent requirements for drug approval and monitoring. Any adverse findings or changes in regulations can impact the market negatively.

3. Patent Expirations: While generic drugs drive market growth, the expiration of patents for brand-name drugs can lead to market saturation, resulting in price wars and reduced profit margins for manufacturers.

Future Outlook

The Hydroxyzine market is poised for continued growth in the coming years, driven by the rising prevalence of anxiety disorders and allergies, the expansion of healthcare infrastructure, and the increasing adoption of generic drugs. However, the market must navigate challenges such as side effects, regulatory hurdles, and competition from alternative medications.

Innovation in drug formulation and delivery methods, along with ongoing research into Hydroxyzine's therapeutic potential, could unlock new opportunities for growth. Additionally, the increasing focus on mental health globally presents a significant market opportunity for Hydroxyzine as an anxiolytic.

Key Player Analysis

ViaCord PerkinElmer (Revvity)

LifeCell International Pvt. Ltd.

Cordlife Group Ltd.

Cryo-Cell International, Inc.

StemCyte, Inc.

CryoHoldco

CBR Systems, Inc.

Maze Cord Blood Laboratories

Cells4Life Group LLP

Vita34 AG

CariCord, Inc.

Cryo-Save AG

Esperite N.V.

CORD BLOOD AMERICA, INC.

NeoStem, Inc.

Segments:

Based on Product Type:

Cord Blood-Derived Growth Factors

Cord Blood Cell Therapy Products

Cord Blood Units

Based on Therapeutic Area:

Oncology

Hematology

Immunology

Metabolic Disorders

Others

Based on Storage Status:

Fresh Cord Blood Products

Frozen Cord Blood Units

Cryopreserved Cord Blood Products

Based on Application:

Transplantation

Regenerative Medicine

Others

Based on End-user:

Hospitals

Cord Blood Banks

Academic and Research Institutes

Specialty Clinics

 Based on the Geography:

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/cord-blood-product-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[mordorintelligencemarketresearch]

The Allergy Diagnostics Industry: Advancing Precision in Allergy Detection and Management

The allergy diagnostics industry plays a pivotal role in addressing a growing global health concern—allergies. Allergies impact millions of people worldwide, manifesting as respiratory issues, skin reactions, food intolerances, and even life-threatening anaphylaxis. As the prevalence of allergic diseases continues to rise due to environmental changes, urbanization, and genetic predisposition, effective diagnostics have become essential for accurate detection, prevention, and management of allergies. 

The allergy diagnostics market has witnessed significant growth due to technological advancements, increased healthcare awareness, and the demand for personalized treatment.     The Allergy Diagnostics Market is estimated to be valued at USD 6.31 billion in 2024 and is projected to reach USD 10.76 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.25% during the forecast period (2024–2029). 

Understanding Allergy Diagnostics 

Allergy diagnostics involves identifying allergens that trigger immune system responses in individuals. Allergens can range from pollen, dust mites, and animal dander to specific foods, drugs, and insect venom. When exposed to allergens, sensitive individuals may exhibit symptoms such as sneezing, itching, swelling, or even severe reactions like anaphylaxis. 

Accurate allergy diagnostics help healthcare providers determine the root cause of allergic reactions, enabling targeted treatment plans, including allergen avoidance, immunotherapy, and symptom management. Diagnostic methods typically include: 

In Vivo Testing: Skin prick tests (SPT), intradermal tests, and patch tests conducted directly on patients. 

In Vitro Testing: Blood-based tests like ImmunoCAP or enzyme-linked immunosorbent assays (ELISA) that identify allergen-specific Immunoglobulin E (IgE) antibodies. 

With growing demand for precise and efficient allergy diagnostics, the industry is undergoing significant innovation to enhance accuracy and accessibility. 

Key Drivers of Growth in the Allergy Diagnostics Industry 

1. Increasing Prevalence of Allergic Diseases 

The rising incidence of allergic conditions such as asthma, allergic rhinitis, eczema, and food allergies is a major driver for the allergy diagnostics industry. According to organizations like the World Health Organization (WHO), hundreds of millions of people suffer from allergies globally, with numbers expected to rise further due to environmental pollution, climate change, and urbanization. 

Food allergies, in particular, have become a growing concern, especially among children, prompting a need for early and precise diagnostics to prevent life-threatening reactions. 

2. Technological Advancements in Allergy Testing 

The allergy diagnostics industry has seen significant technological advancements that enhance the accuracy, speed, and convenience of testing. In vitro testing methods, such as molecular diagnostics and advanced IgE assays, provide reliable results with minimal patient discomfort. Innovations like automated laboratory systems and point-of-care devices are transforming allergy diagnostics, making them more accessible and efficient. 

Additionally, the development of multiplex testing allows clinicians to screen for multiple allergens simultaneously, saving time and resources while delivering comprehensive insights. 

3. Growing Awareness About Allergy Management 

Heightened awareness about allergies and their potential complications has led to increased adoption of diagnostic testing. Public health campaigns, patient education initiatives, and media coverage have emphasized the importance of identifying allergens early to mitigate severe reactions. Parents, in particular, are becoming more proactive in testing their children for food and environmental allergies. 

Healthcare providers are also placing greater focus on preventive care, driving demand for reliable diagnostics as part of early allergy management strategies. 

4. Demand for Personalized Allergy Treatments 

The trend toward personalized medicine is fueling growth in the allergy diagnostics market. Allergy tests provide detailed insights into an individual’s sensitivities, enabling healthcare providers to tailor treatment plans. Personalized immunotherapy, antihistamines, and allergen avoidance strategies are more effective when based on accurate diagnostic data, improving patient outcomes. 

5. Rising Healthcare Expenditure 

Increased healthcare spending, particularly in developed economies, is driving investments in advanced diagnostic tools and technologies. Patients and healthcare providers are now more willing to adopt innovative allergy testing solutions that enhance diagnostic precision and improve long-term allergy management. 

Challenges in the Allergy Diagnostics Industry 

1. Lack of Awareness in Developing Regions 

While awareness about allergies is rising globally, it remains limited in low- and middle-income countries. Many individuals in developing regions may not recognize allergy symptoms or seek timely diagnostic testing, leading to underdiagnosis and inadequate treatment. Improving awareness and accessibility remains a key challenge for industry stakeholders. 

2. High Cost of Advanced Testing 

Advanced allergy diagnostics, particularly molecular tests and multiplex assays, can be expensive, limiting their adoption in resource-constrained settings. While these methods provide high accuracy, affordability remains a barrier for both healthcare providers and patients. 

3. Limited Access to Skilled Professionals 

Effective allergy diagnostics require trained professionals to conduct tests, interpret results, and recommend appropriate treatment. A shortage of allergists, immunologists, and laboratory technicians in certain regions hampers the delivery of quality diagnostic services. 

4. Regulatory Hurdles 

Allergy diagnostic tools must meet stringent regulatory standards for safety, accuracy, and efficacy. Navigating these regulatory processes can delay product launches and market entry, particularly for new technologies and innovations. 

Trends Shaping the Allergy Diagnostics Market 

1. Rise of Molecular Allergy Diagnostics 

Molecular diagnostics are revolutionizing allergy testing by providing detailed information about specific allergenic proteins within a substance. This precision allows clinicians to identify cross-reactivity between allergens and develop highly targeted treatment plans. Molecular diagnostics are gaining popularity for their ability to improve diagnostic accuracy and inform personalized care. 

2. Increasing Adoption of Point-of-Care Testing 

Point-of-care (POC) allergy testing is emerging as a convenient solution for rapid diagnosis, especially in primary care settings. POC devices provide quick results with minimal discomfort, enabling timely diagnosis and treatment without the need for extensive laboratory infrastructure. 

3. Focus on Pediatric Allergy Testing 

The rising prevalence of allergies among children has prompted a strong focus on pediatric allergy diagnostics. Non-invasive, painless testing methods are being developed to address the unique needs of pediatric patients, encouraging early diagnosis and intervention. 

4. Integration of Artificial Intelligence (AI) in Diagnostics 

The integration of AI and machine learning in allergy diagnostics is enhancing result interpretation and clinical decision-making. AI-powered algorithms analyze diagnostic data to identify patterns and predict allergic sensitivities, improving accuracy and efficiency. 

5. Growing Use of Home-Based Allergy Testing Kits 

The COVID-19 pandemic accelerated the adoption of home-based diagnostic tools, including allergy testing kits. These kits allow patients to collect samples at home and send them to labs for analysis, offering convenience and accessibility while maintaining diagnostic accuracy. 

Conclusion 

The allergy diagnostics industry is a critical component of modern healthcare, addressing the growing burden of allergic diseases worldwide. Driven by rising allergy prevalence, technological advancements, and increasing awareness, the industry is witnessing rapid innovation and growth. 

While challenges such as affordability and limited access persist, trends like molecular diagnostics, AI integration, and point-of-care testing are reshaping the landscape, making allergy diagnostics more precise, accessible, and patient-friendly. 

As healthcare systems embrace preventive care and personalized medicine, allergy diagnostics will play an increasingly vital role in improving patient outcomes, enhancing quality of life, and reducing the healthcare burden associated with allergic diseases. By advancing diagnostic accuracy and accessibility, the industry is empowering individuals to better manage allergies and enjoy healthier lives.    For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence: https://www.mordorintelligence.com/industry-reports/allergy-diagnostics-market 

[healthcaremarketanalysis]

Allergy Diagnostics Market worth $9.8 billion by 2029

Allergy Diagnostics Market in terms of revenue was estimated to be worth $5.3 billion in 2024 and is poised to reach $9.8 billion by 2029, growing at a CAGR of 11.0% from 2024 to 2029 according to a new report by MarketsandMarkets™.

Download an Illustrative overview:

Browse in-depth TOC on "Allergy Diagnostics Market"

248 - Tables

57 - Figures

307 – Pages

The consumables segment is expected to account for the largest share in 2023.

The Allergy Diagnostics market, by product & service, has been segmented into consumables, instruments, and services. The consumables segment accounted for the largest share of the Allergy Diagnostics market in 2023. This segment is also anticipated to experience significant growth over the projected period. The increasing demand for rapid diagnosis of allergic patients which is driven by increasing number of allergic cases can be attributed for the larger share of this segment during the forecast period.

In Vivo test segment held the largest market share in the Allergy Diagnostics market.

Based on the test type, the Allergy Diagnostics market is segmented into in vivo tests and in vitro tests. In 2023, the in vivo tests segment accounted for the largest share of the Allergy Diagnostics market. The growth of this segment is mainly driven by the growing adoption of various in vivo tests, such as skin prick tests which is considered as the first line of diagnosis for allergy and favorable government support and guidelines.

Inhaled allergy segment held the largest market share in the Allergy Diagnostics market.

Based on the allergen, the Allergy Diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2023, the inhaled allergens segment accounted for the largest share of the Allergy Diagnostics market due to the rising environmental pollution, rising home dust & mites coupled with other factors such as pollen, fungus, mold, and dust, and switching lifestyles, including rise in indoor activities and exposure to indoor allergen.

North America dominates the global Allergy Diagnostics market

Based on the region, the Allergy Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America market is driven by availability of technologically advanced products and growing research on allergy by companies and government. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. Developing healthcare infrastructure, lifestyle changes and climatic conditions, increased ozone and industrial pollution levels, and the rising demand for quality medical care are some of the major factors driving the growth of this regional market.

Request Sample Pages:

Allergy Diagnostics Market Dynamics:

Drivers:

High incidence and heavy economic burden of allergic diseases

Restraints:

High pricing of allergy diagnostic instruments

Opportunities:

Integration of AI in allergy diagnosis

Challenge:

Shortage of allergists

Key Market Players of Allergy Diagnostics Industry:

Major players in Allergy Diagnostics market include Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan), Minaris Medical America, Inc. (US).

Breakdown of supply-side primary interviews by company type, designation, and region:

By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)

By Designation: C-level (30%), Director-level (20%), and Others (50%)

By Region: North America (36%), Asia- Pacific (27%), Europe (25%), and Latin America- (7%) and MEA-(5%)

Get 10% Free Customization on this Report:

Recent Developments of Allergy Diagnostics Industry:

In 2023, Canon has completed share transfer procedures with Resonac Corporation. This share transfer is intended to be used to purchase the Resonac subsidiaries Minaris Medical Co., Ltd. and Minaris Medical America, Inc. (collectively, "Minaris Medical"). After this share acquisition is finished, Minaris Medical—which runs companies that deal with automated analytical tools and in vitro diagnostic reagents—will be consolidated under Canon Medical.

In 2023, Romer Labs Division Holding GmbH (Austria) acquired CPAK INTER Co., Ltd. (Thailand), a long-time distributor of Romer Labs solutions based in Bangkok. With the acquisition, Romer Labs has achieved yet another significant milestone in the quickly expanding Asian food safety industry.

In 2022, The US Food & Drug Administration (FDA) has cleared ImmunoCAP Specific IgE (sIgE) Allergen Components for use in in vitro diagnostic testing for wheat and sesame allergies, according to a statement from Thermo Fisher Scientific, Inc. (US).

Allergy Diagnostics Market - Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Allergy Diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (global rise in prevalence and heavy economic burden of allergic illnesses, growing environmental pollution, and insurance coverage), restraints (high costs of analyzers and access is limited to healthcare services), opportunities (use of mHealth and integration of AI in allergy diagnosis), and challenges (a few number of allergists and challenges during diagnosis of allergy) influencing the growth of the Allergy Diagnostics market

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Allergy Diagnostics market.

Market Development: Comprehensive information about lucrative markets – the report analyses the Allergy Diagnostics market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Allergy Diagnostics market

Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan) [Minaris Medical America, Inc. (US)], among others in the Allergy Diagnostics market strategies.

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insights: https://www.marketsandmarkets.com/ResearchInsight/allergy-diagnostics-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Content Source: https://www.marketsandmarkets.com/PressReleases/allergy-diagnostics.asp

[globalgrowthinsights]

Ginger Market Developments, Trends & Opportunities till 2032

Ginger Market provides in-depth analysis of the market state of Ginger manufacturers, including best facts and figures, overview, definition, SWOT analysis, expert opinions, and the most current global developments. The research also calculates market size, price, revenue, cost structure, gross margin, sales, and market share, as well as forecasts and growth rates. The report assists in determining the revenue earned by the selling of this report and technology across different application areas.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Ginger in these regions till the forecast period

North America

Middle East and Africa

Asia-Pacific

South America

Europe

Key Attentions of Ginger Market Report:

The report offers a comprehensive and broad perspective on the global Ginger Market.

The market statistics represented in different Ginger segments offers complete industry picture.

Market growth drivers, challenges affecting the development of Ginger are analyzed in detail.

The report will help in the analysis of major competitive market scenario, market dynamics of Ginger.

Major stakeholders, key companies Ginger, investment feasibility and new market entrants study is offered.

Development scope of Ginger in each market segment is covered in this report. The macro and micro-economic factors affecting the Ginger Market

Advancement is elaborated in this report. The upstream and downstream components of Ginger and a comprehensive value chain are explained.

Browse More Details On This Report at @https://www.globalgrowthinsights.com/market-reports/ginger-market-100565

 Global Growth Insights

Web: https://www.globalgrowthinsights.com

Our Other Reports:

Artificial Meat MarketMarket Growth

Dermo-Cosmetics MarketMarket Analysis

Hand Dryers MarketMarket Size

Global Glass Fiber Reinforced Gypsum (GFRG) Panels MarketMarket Share

Global Mountain Bicycles MarketMarket Growth

Aseptic Packaging For The Pharmaceutical MarketMarket

Automotive Simulation MarketMarket Share

Semiconductor Chip Handler MarketMarket Growth Rate

Transcranial Magnetic Stimulator MarketMarket Forecast

Global Cloud Natural Language Processing MarketMarket Size

Education Technology (EdTech) MarketMarket Growth

Digital English Language Learning MarketMarket Analysis

Macromolecule Hydrogel MarketMarket Size

Global Luxury Vinyl tile (LVT) MarketMarket Share

Global Virtual Power Plant MarketMarket Growth

Digital Diagnostics MarketMarket

LED Lens MarketMarket Share

UAV Propellers MarketMarket Growth Rate

Computer Keyboards MarketMarket Forecast

Global Peanut Allergy Therapeutics MarketMarket Size

Advanced Ceramics MarketMarket Growth

Drone Defense System MarketMarket Analysis

Urea Formaldehyde Concentrate (UFC) MarketMarket Size

Global Bike Tube & Tire MarketMarket Share

Global Rhodiola Rosea P.E. MarketMarket Growth

Aerospace Inconel Blisk MarketMarket

Commercial Airport Baggage Handling System MarketMarket Share

Mica Tape for Insulation MarketMarket Growth Rate

Radio Frequency (RF) Energy Harvesting MarketMarket Forecast

Global Architectural Acoustic Panels MarketMarket Size

Arsenic Removal MarketMarket Growth

Carbon Dioxide MarketMarket Analysis

Air Quality Apps MarketMarket Size

Global Positive Temperature Coefficient (PTC) Thermistors MarketMarket Share

Global X-ray Non-Destructive Testing Equipment MarketMarket Growth

Atorvastatin Calcium MarketMarket

Fermentation Airlock MarketMarket Share

Mica Paper MarketMarket Growth Rate

Baggage Towing Tractor MarketMarket Forecast

Global Foldable IOL Market MarketMarket Size

[delveinsight12]

Gluten Sensitivity Market to Witness Growth by 2032 | 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma

DelveInsight's "Gluten Sensitivity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Gluten Sensitivity, historical and forecasted epidemiology as well as the Gluten Sensitivity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Gluten Sensitivity market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Gluten Sensitivity market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Gluten Sensitivity treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Gluten Sensitivity market.

Request for a Free Sample Report @ https://www.delveinsight.com/report-store/gluten-sensitivity-market

Gluten Sensitivity Overview

Gluten sensitivity refers to a spectrum of disorders characterized by an adverse reaction to gluten, a protein found in wheat, barley, rye, and their derivatives. It's important to differentiate between gluten sensitivity and celiac disease, as they are distinct conditions with varying degrees of severity and diagnostic criteria.

Celiac Disease: This is an autoimmune disorder triggered by the ingestion of gluten in genetically predisposed individuals. In celiac disease, the body's immune system responds to gluten by damaging the small intestine, leading to inflammation and affecting nutrient absorption. It can cause a wide range of symptoms, including abdominal pain, bloating, diarrhea, fatigue, weight loss, and nutrient deficiencies. Diagnosis involves blood tests to detect specific antibodies and confirmation through intestinal biopsy.

Non-Celiac Gluten Sensitivity (NCGS): Unlike celiac disease, NCGS does not involve an autoimmune response or damage to the small intestine. Individuals with NCGS experience gastrointestinal symptoms similar to those with celiac disease but lack the specific antibodies and intestinal damage seen in celiac disease. Symptoms may include abdominal pain, bloating, diarrhea, fatigue, headaches, and "brain fog." The diagnosis of NCGS is based on the exclusion of celiac disease and wheat allergy, along with symptom improvement on a gluten-free diet.

Adhering to a gluten-free diet is the primary treatment for both celiac disease and NCGS. This involves avoiding foods that contain wheat, barley, rye, and their derivatives. Nowadays, there is increased awareness and availability of gluten-free products to support those with gluten-related disorders.

Learn more about Gluten Sensitivity, treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/gluten-sensitivity-market

Gluten Sensitivity Market 

The Gluten Sensitivity market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Gluten Sensitivity market trends by analyzing the impact of current Gluten Sensitivity therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Gluten Sensitivity market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Gluten Sensitivity market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Gluten Sensitivity market in 7MM is expected to witness a major change in the study period 2019-2032.

Request a sample and discover more about the report offerings at:

Gluten Sensitivity Epidemiology 

The Gluten Sensitivity epidemiology section provides insights into the historical and current Gluten Sensitivity patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Gluten Sensitivity market report also provides the diagnosed patient pool, trends, and assumptions. 

Gluten Sensitivity Drugs Uptake

This section focuses on the uptake rate of the potential Gluten Sensitivity drugs recently launched in the Gluten Sensitivity market or expected to be launched in 2019-2032. The analysis covers the Gluten Sensitivity market uptake by drugs, patient uptake by therapies, and sales of each drug.   

Gluten Sensitivity Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Gluten Sensitivity market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Gluten Sensitivity Pipeline Development Activities

The Gluten Sensitivity report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Gluten Sensitivity key players involved in developing targeted therapeutics.

Gluten Sensitivity Therapeutics Assessment

Major key companies such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma, and others are working proactively in the Gluten Sensitivity Therapeutics market to develop novel therapies which will drive the Gluten Sensitivity treatment markets in the upcoming years.

Learn more about the emerging therapies & key companies at: https://www.delveinsight.com/report-store/gluten-sensitivity-market

Trending Reports by DelveInsight:

Bullous Pemphigoid Market | Congenital Myasthenic Syndromes Market | Cryopyrin-associated Periodic Syndrome Market | Glycogen Storage Disease Market | Inflammatory Breast Cancer Market | Lag-3-next Generation Immunotherapy Market | Metastatic Colorectal Cancer Market | Secondary Hyperparathyroidism Market | Dermatomyositis Market | Tenosynovial Giant Cell Tumors Market 

dyspepsia market | monoclonal gammopathy of undetermined significance market | oral electrolyte solutions market | ventral hernia market | gene therapy in CNS disorder market | myeloproliferative neoplasms market | nk cell therapy market | spinal implants market | thyroid cancer market | attention deficit hyperactivity disorder adhd market 

About DelveInsight:

DelveInsight is a prominent business consultant and market research firm specializing in the life sciences sector. With a focus on supporting pharmaceutical companies, DelveInsight provides end-to-end solutions to enhance their performance.

Connect with DelveInsight:

LinkedIn | Facebook | Twitter

Contact Us:

Kritika RehaniTeam Lead, Marketing

krehani@delveinsight.com

+91-9650213330

www.delveinsight.com